|
|
Article: DuPont Merck, IRORI Quantum Microchemistry Agree to Jointly Develop New Drug Leads
- Article from:
- PR Newswire
- Article date:
- June 24, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WILMINGTON, Del., June 24 /PRNewswire/ -- The DuPont Merck Pharmaceutical Company and IRORI Quantum Microchemistry have entered into an alliance to construct chemical compound libraries to screen for development of potential drug compounds.
IRORI, located in La Jolla, CA, will use its Memory-based Directed Sorted(TM) methodologies to produce small-molecule libraries, based on DuPont Merck's selected pharmacophores, and drug leads which DuPont Merck will screen for activity.
Financial details of the agreement were not made public. DuPont Merck, headquartered in Wilmington, DE, will provide IRORI upfront and milestone payments as well as royalties ...